Skip to main content
. 2023 Oct 5;5(12):100734. doi: 10.1016/j.xkme.2023.100734

Table 2.

Participants’ Completion of ACT Program Components in the Intention-to-Treat ACT Group During 90-Day Follow-Up

ACT Program Component N=15
Inpatient education 14 (93)
Outpatient laboratory monitoring
 Serum creatinine 15 (100)
 Urine studies 14 (93)
PCP visit 14 (93)
Pharmacist visit 11 (73)

Note: Data reported as n (%).

Abbreviations: ACT, AKI in Care Transition; PCP, primary care provider.